Revenio Group Oyj (CHIX:REG1VH) ROC %: 6.17% (As of Mar. 2026)


CHIX:REG1VH Revenio Group Oyj CHIX:REG1VH
80 GF Score
Price €16.47
GF Value €40.41
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Revenio Group Oyj ROC %?

Revenio Group Oyj CHIX:REG1VH 80 ROC % is 6.17% as of Mar. 2026. GuruFocus rates CHIX:REG1VH with a GF Score™ of 80/100 and a GF Value™ of €40.41 (Significantly Undervalued). The stock has 2 warning signs investors should review.

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. Revenio Group Oyj's annualized return on capital (ROC %) for the quarter that ended in Mar. 2026 was 6.17%.

As of today (2026-06-28), Revenio Group Oyj's WACC % is 5.44%. Revenio Group Oyj's ROC % is 14.70% (calculated using TTM income statement data). Revenio Group Oyj generates higher returns on investment than it costs the company to raise the capital needed for that investment. It is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases.


Revenio Group Oyj  (CHIX:REG1Vh) ROC % Explanation

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Revenio Group Oyj's WACC % is 5.44%. Revenio Group Oyj's ROC % is 14.70% (calculated using TTM income statement data). Revenio Group Oyj generates higher returns on investment than it costs the company to raise the capital needed for that investment. It is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases.


Be Aware

Like ROE % and ROA %, ROC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


Revenio Group Oyj ROC % Related Terms


Revenio Group Oyj ROC % Historical Data

* Premium members only.

The historical data trend for Revenio Group Oyj's ROC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Revenio Group Oyj ROC % Chart

Revenio Group Oyj Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.97 20.81 19.46 17.10 16.96

Revenio Group Oyj Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.98 15.48 17.05 19.52 6.17
CHIX:REG1VH
80GF Score
Revenio Group Oyj CHIX:REG1VH
ROC % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Revenio Group Oyj ROC % Calculation

Revenio Group Oyj's annualized Return on Capital (ROC %) for the fiscal year that ended in Dec. 2025 is calculated as:

ROC % (A: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Dec. 2024 ) + Invested Capital (A: Dec. 2025 ))/ count )
=25.412 * ( 1 - 23.72% )/( (113.622 + 114.992)/ 2 )
=19.3842736/114.307
=16.96 %

where

Revenio Group Oyj's annualized Return on Capital (ROC %) for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=9.2 * ( 1 - 24.24% )/( (114.992 + 111)/ 2 )
=6.96992/112.996
=6.17 %

where

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data. The tax rate is limited to between 0% and 100%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROC % →
What does a ROC % of 6.17% mean?
Revenio Group Oyj (CHIX:REG1VH) has a ROC % of 6.17% as of Mar. 2026. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on Revenio Group Oyj and its competitors.
Is Revenio Group Oyj's ROC % too high?
Revenio Group Oyj's current ROC % is 6.17%. The Medical Devices & Instruments industry median ROC % is 1.26. Revenio Group Oyj's value of 6.17% is 389.7% above this industry median. Overall, Revenio Group Oyj has a GF Score™ of 80/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Revenio Group Oyj's ROC % compare to ABT and SYK?
Revenio Group Oyj's ROC % of 6.17% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROC % is 1.26. Revenio Group Oyj's value of 6.17% is 389.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC % for a Medical Devices & Instruments company?
The median ROC % among Medical Devices & Instruments companies is 1.26, based on 847 companies in the industry. Companies in the top quartile (top 25%) have a ROC % significantly above this median, while those in the bottom quartile fall well below. However, ROC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Revenio Group Oyj's current ROC % of 6.17% is 389.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC % mean?
A high ROC % can signal that a stock is expensive relative to its fundamentals. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on Revenio Group Oyj and its competitors. For the Medical Devices & Instruments industry, the median ROC % is 1.26 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Revenio Group Oyj's current ROC % is 6.17%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Revenio Group Oyj stock overvalued right now?
Based on GuruFocus' analysis, Revenio Group Oyj (CHIX:REG1VH) is currently considered Significantly Undervalued. The stock's GF Value™ is €40.41, compared to a current price of €16.47 — trading 59.2% below its estimated fair value. The current ROC % is 6.17% and 389.7% above the Medical Devices & Instruments industry median of 1.26. Revenio Group Oyj's overall GF Score™ is 80/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC % calculated?
ROC % is calculated from a company's financial statements. For Revenio Group Oyj (CHIX:REG1VH), the current ROC % is 6.17% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Revenio Group Oyj (CHIX:REG1VH) Overvalued in 2026?

Based on GuruFocus' analysis, Revenio Group Oyj stock appears to be undervalued. The current stock price of €16.47 is trading 59.2% below its estimated GF Value™ of €40.41. GuruFocus considers Revenio Group Oyj to be Significantly Undervalued.

Key valuation signals for CHIX:REG1VH:

  • ROC %: 6.17%
  • GF Value™: €40.41 vs. price of €16.47 (59.2% below fair value)
  • GF Score™: 80/100 with 2 warning signs
  • Industry Position: 389.7% above the Medical Devices & Instruments median

No single metric tells the full story. See the CHIX:REG1VH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Revenio Group Oyj Business Description

Address Harkahaankuja 7, Vantaa, FIN, 01730
Revenio Group Oyj is a Finnish health technology company. It develops and commercializes effective, easy-to-use health tech-related screening devices for detecting diseases of public health significance. Its ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), and perimeter and fundus imaging devices under the iCare brand. Its eye care software platform, Oculo, offers clinical communication, telehealth, remote patient monitoring, and data analytics capabilities. The company generates the majority of its revenue from the United States.
80GF Score

Get the complete analysis for CHIX:REG1VH

ROC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€16.47
Price
€40.41
GF Value